CHICAGO EQUITY PARTNERS LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$716,000
+6.2%
15,140
+35.8%
0.07%
+84.6%
Q4 2019$674,000
-0.1%
11,150
-1.1%
0.04%
+21.9%
Q3 2019$675,000
-28.9%
11,270
-23.7%
0.03%
-23.8%
Q2 2019$950,000
+24.2%
14,780
+56.7%
0.04%
+40.0%
Q1 2019$765,000
-44.4%
9,430
-71.4%
0.03%
-28.6%
Q2 2018$1,376,000
-19.7%
33,010
-15.0%
0.04%
-23.6%
Q1 2018$1,713,000
-12.3%
38,8550.0%0.06%
-8.3%
Q4 2017$1,954,000
-0.8%
38,8550.0%0.06%
-3.2%
Q3 2017$1,970,000
+39.4%
38,855
+39.9%
0.06%
+63.2%
Q2 2017$1,413,00027,7700.04%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,046$126,5576.89%
M28 Capital Management LP 126,300$4,513,9625.10%
Bellevue Group AG 9,511,900$339,955,3064.93%
Deep Track Capital, LP 2,834,069$101,289,6264.16%
BVF INC/IL 2,560,761$91,521,5983.35%
Sicart Associates LLC 210,698$7,530,3472.93%
Privium Fund Management B.V. 182,773$6,532,3072.19%
Camber Capital Management LP 1,925,000$68,8002.12%
Orbimed Advisors 2,124,500$75,929,6301.49%
SECTOR GAMMA AS 146,441$5,233,8011.27%
View complete list of IONIS PHARMACEUTICALS INC shareholders